semaglutide manufacturing process novo nordisk FDA rebukes on production, permission issues uncovered in March inspection PDF) Semaglutide (Ozempic and Wegovy)

A fresh analysis of the clinical and financial implications of comprehensive coverage in Medicare of GLP-1s for all current FDA indications (type 2 diabetes, obesity, heart disease and metabolic-associated steatohepatitis) offers some hope for long-term cost savings

Another arm of the trial involved switching some patients who were on semaglutide to a dummy jab after six months without them knowing which injection they were getting

Despite the overlap between T2DM and CVD, antidiabetic therapeutics were either discovered by chance or designed to target metabolic, rather than cardiovascular, mechanisms

But it seems to be working out okay I had a rough start, I need to wait a bit and start over